摘要
本文就重组人甲状旁腺素治疗骨质疏松症的研究概况作一综述,重点介绍重组人甲状旁腺素(1- 34)和重组人甲状旁腺素(1-84)的药理毒理和临床研究工作,为研究和开发甲状旁腺素提供参考。
The reviewed in this paper, progress on treatment of osteoporosis with recombinant human parathyroid hormones was mainly on pharmacology ,toxicology, and clinical pharmacology of recombinant human parathyroid hormone (1-34) and recombinant human parathyroid hormone (1-84) in order to provide references for the research and development of parathyroid hormone.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2006年第4期302-306,共5页
Chinese Journal of New Drugs and Clinical Remedies
基金
国家高技术研究发展计划(863计划)(2002AA2Z345A)